Cargando…
Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate
AIMS: Dosimeteric and radiobiological comparison of two radiation schedules in localized carcinoma prostate: Standard Three-Dimensional Conformal Radiotherapy (3DCRT) followed by Intensity Modulated Radiotherapy (IMRT) boost (sequential-IMRT) with Simultaneous Integrated Boost IMRT (SIB-IMRT). MATER...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507400/ https://www.ncbi.nlm.nih.gov/pubmed/23204659 http://dx.doi.org/10.4103/0970-1591.102707 |
_version_ | 1782251068369928192 |
---|---|
author | Bansal, A. Kapoor, R. Singh, S. K. Kumar, N. Oinam, A. S. Sharma, S. C. |
author_facet | Bansal, A. Kapoor, R. Singh, S. K. Kumar, N. Oinam, A. S. Sharma, S. C. |
author_sort | Bansal, A. |
collection | PubMed |
description | AIMS: Dosimeteric and radiobiological comparison of two radiation schedules in localized carcinoma prostate: Standard Three-Dimensional Conformal Radiotherapy (3DCRT) followed by Intensity Modulated Radiotherapy (IMRT) boost (sequential-IMRT) with Simultaneous Integrated Boost IMRT (SIB-IMRT). MATERIAL AND METHODS: Thirty patients were enrolled. In all, the target consisted of PTV P + SV (Prostate and seminal vesicles) and PTV LN (lymph nodes) where PTV refers to planning target volume and the critical structures included: bladder, rectum and small bowel. All patients were treated with sequential-IMRT plan, but for dosimetric comparison, SIB-IMRT plan was also created. The prescription dose to PTV P + SV was 74 Gy in both strategies but with different dose per fraction, however, the dose to PTV LN was 50 Gy delivered in 25 fractions over 5 weeks for sequential-IMRT and 54 Gy delivered in 27 fractions over 5.5 weeks for SIB-IMRT. The treatment plans were compared in terms of dose–volume histograms. Also, Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) obtained with the two plans were compared. RESULTS: The volume of rectum receiving 70 Gy or more (V > 70 Gy) was reduced to 18.23% with SIB-IMRT from 22.81% with sequential-IMRT. SIB-IMRT reduced the mean doses to both bladder and rectum by 13% and 17%, respectively, as compared to sequential-IMRT. NTCP of 0.86 ± 0.75% and 0.01 ± 0.02% for the bladder, 5.87 ± 2.58% and 4.31 ± 2.61% for the rectum and 8.83 ± 7.08% and 8.25 ± 7.98% for the bowel was seen with sequential-IMRT and SIB-IMRT plans respectively. CONCLUSIONS: For equal PTV coverage, SIB-IMRT markedly reduced doses to critical structures, therefore should be considered as the strategy for dose escalation. SIB-IMRT achieves lesser NTCP than sequential-IMRT. |
format | Online Article Text |
id | pubmed-3507400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35074002012-11-30 Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate Bansal, A. Kapoor, R. Singh, S. K. Kumar, N. Oinam, A. S. Sharma, S. C. Indian J Urol Original Article AIMS: Dosimeteric and radiobiological comparison of two radiation schedules in localized carcinoma prostate: Standard Three-Dimensional Conformal Radiotherapy (3DCRT) followed by Intensity Modulated Radiotherapy (IMRT) boost (sequential-IMRT) with Simultaneous Integrated Boost IMRT (SIB-IMRT). MATERIAL AND METHODS: Thirty patients were enrolled. In all, the target consisted of PTV P + SV (Prostate and seminal vesicles) and PTV LN (lymph nodes) where PTV refers to planning target volume and the critical structures included: bladder, rectum and small bowel. All patients were treated with sequential-IMRT plan, but for dosimetric comparison, SIB-IMRT plan was also created. The prescription dose to PTV P + SV was 74 Gy in both strategies but with different dose per fraction, however, the dose to PTV LN was 50 Gy delivered in 25 fractions over 5 weeks for sequential-IMRT and 54 Gy delivered in 27 fractions over 5.5 weeks for SIB-IMRT. The treatment plans were compared in terms of dose–volume histograms. Also, Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) obtained with the two plans were compared. RESULTS: The volume of rectum receiving 70 Gy or more (V > 70 Gy) was reduced to 18.23% with SIB-IMRT from 22.81% with sequential-IMRT. SIB-IMRT reduced the mean doses to both bladder and rectum by 13% and 17%, respectively, as compared to sequential-IMRT. NTCP of 0.86 ± 0.75% and 0.01 ± 0.02% for the bladder, 5.87 ± 2.58% and 4.31 ± 2.61% for the rectum and 8.83 ± 7.08% and 8.25 ± 7.98% for the bowel was seen with sequential-IMRT and SIB-IMRT plans respectively. CONCLUSIONS: For equal PTV coverage, SIB-IMRT markedly reduced doses to critical structures, therefore should be considered as the strategy for dose escalation. SIB-IMRT achieves lesser NTCP than sequential-IMRT. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3507400/ /pubmed/23204659 http://dx.doi.org/10.4103/0970-1591.102707 Text en Copyright: © Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Bansal, A. Kapoor, R. Singh, S. K. Kumar, N. Oinam, A. S. Sharma, S. C. Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate |
title | Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate |
title_full | Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate |
title_fullStr | Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate |
title_full_unstemmed | Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate |
title_short | Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost–IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate |
title_sort | dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential imrt plan) with simultaneous integrated boost–imrt (sib imrt) treatment plan in patients with localized carcinoma prostate |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507400/ https://www.ncbi.nlm.nih.gov/pubmed/23204659 http://dx.doi.org/10.4103/0970-1591.102707 |
work_keys_str_mv | AT bansala dosimetriccomparisonofstandardthreedimensionalconformalradiotherapyfollowedbyintensitymodulatedradiotherapyboostschedulesequentialimrtplanwithsimultaneousintegratedboostimrtsibimrttreatmentplaninpatientswithlocalizedcarcinomaprostate AT kapoorr dosimetriccomparisonofstandardthreedimensionalconformalradiotherapyfollowedbyintensitymodulatedradiotherapyboostschedulesequentialimrtplanwithsimultaneousintegratedboostimrtsibimrttreatmentplaninpatientswithlocalizedcarcinomaprostate AT singhsk dosimetriccomparisonofstandardthreedimensionalconformalradiotherapyfollowedbyintensitymodulatedradiotherapyboostschedulesequentialimrtplanwithsimultaneousintegratedboostimrtsibimrttreatmentplaninpatientswithlocalizedcarcinomaprostate AT kumarn dosimetriccomparisonofstandardthreedimensionalconformalradiotherapyfollowedbyintensitymodulatedradiotherapyboostschedulesequentialimrtplanwithsimultaneousintegratedboostimrtsibimrttreatmentplaninpatientswithlocalizedcarcinomaprostate AT oinamas dosimetriccomparisonofstandardthreedimensionalconformalradiotherapyfollowedbyintensitymodulatedradiotherapyboostschedulesequentialimrtplanwithsimultaneousintegratedboostimrtsibimrttreatmentplaninpatientswithlocalizedcarcinomaprostate AT sharmasc dosimetriccomparisonofstandardthreedimensionalconformalradiotherapyfollowedbyintensitymodulatedradiotherapyboostschedulesequentialimrtplanwithsimultaneousintegratedboostimrtsibimrttreatmentplaninpatientswithlocalizedcarcinomaprostate |